Hjortsberg, C. et al. 1999. Cost-effectiveness Analysis of Pegylated-liposomal Doxorubicin and Liposomal Daunorubicin Treatments in Patients with Kaposi’s Sarcoma. Acta Oncologica. 38, 8 (Jan. 1999), 1063–1067. DOI:https://doi.org/10.1080/028418699432374.